Your browser does not support iframes.
Carolinas Inc - Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Biolase Technology, Inc.
(NQ:
BIOL
)
3.940
USD
-0.040 (-1.01%)
Streaming Delayed Price
/ Updated:
1:58 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
211,861
Open
4.010
Bid (Size)
3.920 (200)
Ask (Size)
3.940 (100)
Prev. Close
3.980
Today's Range
3.830 - 4.020
52wk Range
1.470 - 6.020
Shares Outstanding
31,737,244
Dividend Yield
N/A
Top News
More News
RDInvesting Provides Investors with Free In-Depth Equity Reports on BIOL, FRO, KNDI and SGOC
June 18, 2013
from
ACCESSWIRE
BIOLASE Added to Two Major Indices for 2013
June 17, 2013
Widely-Followed Russell 3000 and Russell Global Indices Will Include BIOLASE, Inc.
Read More
from
Marketwired News Releases
More News
Read More
Preliminary Russell 3000 Addition Pushing Stocks Around
June 17, 2013
from
StreetInsider.com News Articles
WallachBeth Capital Starts Biolase (BIOL) at Buy
June 17, 2013
from
StreetInsider.com News Articles
BIOLASE Adds Two New Independent Directors to Its Board
June 10, 2013
from
Marketwired News Releases
BIOLASE Names Current Director Alexander K. Arrow President and Chief Operating Officer
June 07, 2013
from
Marketwired News Releases
BIOLASE Holds Annual Meeting of Shareholders
June 07, 2013
from
Marketwired News Releases
BIOLASE, Inc. Responds to Shareholder Inquiries
June 06, 2013
from
Marketwired News Releases
BIOLASE (BIOL) Given New Patent for Treating Broad Range of Eye Conditions
May 30, 2013
category
Stocks
from
TransWorldNews Current Releases
BIOLASE Issued Broad New Patent for Treating Eye Conditions, Including Presbyopia, Cataracts, and Glaucoma
May 29, 2013
from
Marketwired News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.